Boris Jülg

5.4k total citations · 2 hit papers
48 papers, 2.0k citations indexed

About

Boris Jülg is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Boris Jülg has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Virology, 25 papers in Immunology and 21 papers in Infectious Diseases. Recurrent topics in Boris Jülg's work include HIV Research and Treatment (29 papers), Immune Cell Function and Interaction (18 papers) and HIV/AIDS drug development and treatment (11 papers). Boris Jülg is often cited by papers focused on HIV Research and Treatment (29 papers), Immune Cell Function and Interaction (18 papers) and HIV/AIDS drug development and treatment (11 papers). Boris Jülg collaborates with scholars based in United States, Germany and United Kingdom. Boris Jülg's co-authors include Vlatka Zoldoš, Petra Korać, Aleksandar Vojta, Luka Bočkor, Paula Dobrinić, Vanja Tadić, Marija Klasić, Dan H. Barouch, Bruce D. Walker and Florencia Pereyra and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Boris Jülg

48 papers receiving 2.0k citations

Hit Papers

Repurposing the CRISPR-Cas9 system for targeted DNA methy... 2016 2026 2019 2022 2016 2023 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Jülg United States 22 849 808 641 549 308 48 2.0k
Donna L. Mallery United Kingdom 24 396 0.5× 1.4k 1.8× 833 1.3× 776 1.4× 353 1.1× 29 2.9k
Rosemay Vazeux France 20 994 1.2× 472 0.6× 671 1.0× 485 0.9× 323 1.0× 28 2.0k
Jonah B. Sacha United States 25 835 1.0× 352 0.4× 981 1.5× 403 0.7× 378 1.2× 67 1.7k
Ester Ballana Spain 28 752 0.9× 705 0.9× 568 0.9× 653 1.2× 351 1.1× 76 2.0k
Joost Louwagie United States 20 1.5k 1.8× 531 0.7× 361 0.6× 1.3k 2.3× 339 1.1× 27 2.4k
Takao Masuda Japan 36 1.2k 1.4× 1.0k 1.3× 1.5k 2.4× 843 1.5× 438 1.4× 130 3.5k
Marina Zaitseva United States 29 850 1.0× 420 0.5× 1.1k 1.8× 361 0.7× 324 1.1× 56 2.3k
Miles W. Cloyd United States 28 1.3k 1.5× 408 0.5× 760 1.2× 703 1.3× 472 1.5× 55 2.1k
Velpandi Ayyavoo United States 27 1.4k 1.7× 951 1.2× 1.1k 1.8× 721 1.3× 434 1.4× 85 2.5k
Yong‐Hui Zheng United States 33 1.7k 2.1× 1.0k 1.3× 850 1.3× 1.0k 1.9× 862 2.8× 82 3.0k

Countries citing papers authored by Boris Jülg

Since Specialization
Citations

This map shows the geographic impact of Boris Jülg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Jülg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Jülg more than expected).

Fields of papers citing papers by Boris Jülg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Jülg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Jülg. The network helps show where Boris Jülg may publish in the future.

Co-authorship network of co-authors of Boris Jülg

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Jülg. A scholar is included among the top collaborators of Boris Jülg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Jülg. Boris Jülg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartsch, Yannic C., et al.. (2025). Combinatorial Fc modifications for complementary antibody functionality. mAbs. 17(1). 2465391–2465391. 1 indexed citations
2.
Beukenhorst, Anna L., Jacopo Frallicciardi, Martin H. Koldijk, et al.. (2024). A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration. Scientific Reports. 14(1). 3818–3818. 10 indexed citations
3.
Chen, Benjamin K., et al.. (2023). Viral persistence, reactivation, and mechanisms of long COVID. eLife. 12. 112 indexed citations breakdown →
4.
Herman, Jonathan D., Chuangqi Wang, John S. Burke, et al.. (2022). Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy. Cell Reports Medicine. 3(11). 100811–100811. 17 indexed citations
5.
Kapłonek, Paulina, Stephanie Fischinger, Deniz Cizmeci, et al.. (2022). mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern. Immunity. 55(2). 355–365.e4. 59 indexed citations
6.
Karsten, Christina B., Yannic C. Bartsch, Sally Shin, et al.. (2022). Evolution of functional antibodies following acute Epstein-Barr virus infection. PLoS Pathogens. 18(9). e1010738–e1010738. 11 indexed citations
7.
Herman, Jonathan D., Chuangqi Wang, Carolin Loos, et al.. (2021). Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response. Nature Communications. 12(1). 6853–6853. 21 indexed citations
8.
Das, Jishnu, Caitlyn Linde, Todd J. Suscovich, et al.. (2020). Mining for humoral correlates of HIV control and latent reservoir size. PLoS Pathogens. 16(10). e1008868–e1008868. 16 indexed citations
9.
Chen, Zhilin & Boris Jülg. (2020). Therapeutic Vaccines for the Treatment of HIV. Translational research. 223. 61–75. 28 indexed citations
10.
Yu, Wen‐Han, David Su, Christine M. Fennessey, et al.. (2019). Predicting the broadly neutralizing antibody susceptibility of the HIV reservoir. JCI Insight. 4(17). 23 indexed citations
11.
Jülg, Boris, Po-Ting Liu, Kshitij Wagh, et al.. (2017). Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail. Science Translational Medicine. 9(408). 96 indexed citations
12.
Vojta, Aleksandar, Paula Dobrinić, Vanja Tadić, et al.. (2016). Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Research. 44(12). 5615–5628. 554 indexed citations breakdown →
13.
Jülg, Boris, Danielle N. Poole, Musie Ghebremichael, et al.. (2012). Factors Predicting Discordant Virological and Immunological Responses to Antiretroviral Therapy in HIV-1 Clade C Infected Zulu/Xhosa in South Africa. PLoS ONE. 7(2). e31161–e31161. 17 indexed citations
14.
Varadarajan, Navin, Boris Jülg, Yvonne J. Yamanaka, et al.. (2011). A high-throughput single-cell analysis of human CD8+ T cell functions reveals discordance for cytokine secretion and cytolysis. Journal of Clinical Investigation. 121(11). 4322–4331. 123 indexed citations
15.
Jülg, Boris, Florencia Pereyra, María J. Buzón, et al.. (2010). Infrequent Recovery of HIV from but Robust Exogenous Infection of Activated CD4+T Cells in HIV Elite Controllers. Clinical Infectious Diseases. 51(2). 233–238. 86 indexed citations
16.
Chen, Huabiao, Alicja Piechocka‐Trocha, Toshiyuki Miura, et al.. (2009). Differential Neutralization of Human Immunodeficiency Virus (HIV) Replication in Autologous CD4 T Cells by HIV-Specific Cytotoxic T Lymphocytes. Journal of Virology. 83(7). 3138–3149. 72 indexed citations
17.
Jülg, Boris, Sven Weidner, & Doris Mayr. (2005). Pulmonary manifestation of a Langerhans cell sarcoma: case report and review of the literature. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 448(3). 369–374. 30 indexed citations
18.
Jülg, Boris & F. D. Goebel. (2005). Susceptibility to HIV/AIDS: An Individual Characteristic We Can Measure?. Infection. 33(3). 160–162. 9 indexed citations
19.
Jülg, Boris & F. D. Goebel. (2005). What's New in HIV/AIDS? Neutralizing HIV Antibodies: Do they Really Protect?. Infection. 33(5-6). 405–407. 3 indexed citations
20.
Jülg, Boris & F. D. Goebel. (2005). What’s New in HIV/AIDS? Chemokine Receptor Antagonists: A New Era of HIV Therapy?. Infection. 33(5-6). 408–410. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026